Skip to main content

Table 2.

The association between maternal BMI and smoking status in pregnancy and levels of maternal thyroid-stimulating hormone (TSH) and free thyroxine (T4) in the early pregnancy assessed using different biochemical methods.

n TSH (mIU/L)a TSH (mIU/L)b Free T4 (pmol/L)a Free T4 (pmol/L)b
Meanc d 95% CI Meanc d 95% CI Meanc d 95% CI Meanc d 95% CI
BMI (kg/m2)e
 <18.5 216 0.887 0.911 0.801–1.04 0.778 0.910 0.800–1.04 17.2 1.02 1.01–1.04 16.7 1.02 1.01–1.04
 18.5–24.9 3096 0.985 Ref. 0.861 Ref. 16.8 Ref. 16.3 Ref.
 25.0–29.9 1350 1.05 1.07 1.01–1.13 0.917 1.07 1.01–1.14 16.4 0.974 0.965–0.982 16.2 0.988 0.980–0.996
 30.0–34.9 571 1.17 1.19 1.10–1.30 1.03 1.20 1.10–1.30 16.2 0.963 0.952–0.975 16.0 0.981 0.970–0.993
 ≥35.0 296 1.31 1.34 1.20–1.50 1.16 1.35 1.20–1.51 16.0 0.953 0.938–0.968 15.9 0.976 0.961–0.991
Smokingf
 Non-smoking 4958 1.04 Ref. 0.909 Ref. 16.7 Ref. 16.3 Ref.
 Smoking 571 0.930 0.875 0.806–0.950 0.838 0.901 0.830–0.978 16.1 0.969 0.958–0.980 16.1 0.988 0.977–0.999

aMethod A (Cobas 8000, Roche Diagnostics). bMethod B (ADVIA Centaur XPT, Siemens Healthineers). cGeometric mean. dAdjusted model included maternal BMI, smoking, age, parity, gestational week of blood sampling, origin, and diabetes. eMaternal pre-pregnancy BMI. fMaternal smoking in the pregnancy.

aβ, adjusted exponentiated beta coefficient.